- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Solasia Pharma KK (4597)
Assess today's live Solasia Pharma KK (4597) share price, performance and insights using our live Tokyo: 4597 stock exchange data.
Analyse the historical data and Solasia Pharma KK share price performance charts on this page. Our technical summary section provides analysis on Solasia Pharma share price buy/sell indicators using real-time data (or discuss the Solasia Pharma (4597) stock price today with other investors in the Solasia Pharma TYO share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TYO 4597 share price (ISIN: JP3436500007) to enhance your trading decisions with our free investment tools and resources.
What Is the Solasia Pharma KK Share Price Today?
The Solasia Pharma share price today is 38.0.
What Is the Stock Symbol for Solasia Pharma KK
The stock symbol (or 'ticker') for Solasia Pharma KK is "4597."
What Stock Exchange Does Solasia Pharma KK Trade On?
Solasia Pharma KK is listed and trades on the Tokyo stock exchange.
Is Solasia Pharma KK a Good Stock to Buy?
Determining whether Solasia Pharma KK—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Solasia Pharma KK share price performance charts on this page. Our technical summary section provides analysis on Solasia Pharma share price buy/sell indicators using real-time data (or discuss the Solasia Pharma (4597) stock price today with other investors in the Solasia Pharma TYO share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TYO 4597 share price (ISIN: JP3436500007) to enhance your trading decisions with our free investment tools and resources.
What Is the Solasia Pharma KK Share Price Today?
The Solasia Pharma share price today is 38.0.
What Is the Stock Symbol for Solasia Pharma KK
The stock symbol (or 'ticker') for Solasia Pharma KK is "4597."
What Stock Exchange Does Solasia Pharma KK Trade On?
Solasia Pharma KK is listed and trades on the Tokyo stock exchange.
Is Solasia Pharma KK a Good Stock to Buy?
Determining whether Solasia Pharma KK—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Tokyo
Currency in JPY
38.0
-1.0(-2.56%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.0
39.0
52 wk Range
23.0
70.0
4597 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.039.0
52 wk Range
23.070.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4597 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
120.0
Upside
+215.79%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
No news in this category
Looks like there are no results in this news category
Solasia Pharma Company Profile
Solasia Pharma K.K. engages in the development and marketing of oncology drugs in Japan and other Asian countries. The company offers Episil, an oral liquid for oral mucositis/stomatitis; DARVIAS, an antineoplastic agent injection for relapsed or refractory peripheral T-cell lymphoma; and Sancuso for chemotherapy induced nausea and vomiting. It also develops SP-04, which is in preclinical trial development to treat chemotherapy peripheral neuropathy; and SP-04, which is in preclinical trial development for the treatment of colorectal cancer. The company was founded in 2006 and is based in Tokyo, Japan.
Compare 4597 to Peers and Sector
Metrics to compare | 4597 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4597PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.4x | −5.0x | −0.5x | |
PEG Ratio | 0.09 | −0.27 | 0.00 | |
Price/Book | 7.4x | 3.6x | 2.6x | |
Price / LTM Sales | 26.9x | 48.8x | 3.0x | |
Upside (Analyst Target) | 200.0% | 48.5% | 54.7% | |
Fair Value Upside | Unlock | 13.9% | 9.3% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 120.0
(+215.79% Upside)
Earnings
Latest Release
Feb 12, 2025
EPS / Forecast
-5.24 / --
Revenue / Forecast
235.00M / --
People Also Watch
FAQ
What Is the Solasia Pharma (4597) Stock Price Today?
The Solasia Pharma stock price today is 38.00
What Stock Exchange Does Solasia Pharma Trade On?
Solasia Pharma is listed and trades on the Tokyo stock exchange.
What Is the Stock Symbol for Solasia Pharma?
The stock symbol for Solasia Pharma is "4597."
What Is the Solasia Pharma Market Cap?
As of today, Solasia Pharma market cap is 8.29B.
What is Solasia Pharma Earnings Per Share?
The Solasia Pharma EPS is -9.77.
What Is the Next Solasia Pharma Earnings Date?
Solasia Pharma will release its next earnings report on 13 May 2025.
From a Technical Analysis Perspective, Is 4597 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.